This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Michael G. Babich | |
|---|---|
| Name | Michael G. Babich |
| Occupation | Physician; Researcher; Entrepreneur |
| Known for | Interventional neuroradiology; Endovascular therapies; Medical device development |
Michael G. Babich
Michael G. Babich is an American physician, interventionalist, researcher, and entrepreneur known for contributions to endovascular therapies, interventional neuroradiology, and medical device innovation. He has held clinical appointments, led translational research programs, founded healthcare companies, and authored scientific publications and patents that intersect with neuroscience, vascular medicine, and medical technology.
Babich completed undergraduate studies and professional training in institutions that have produced clinicians and researchers associated with Harvard Medical School, Johns Hopkins University, Stanford University School of Medicine, and Mayo Clinic College of Medicine and Science alumni. He pursued medical degree and residency training in settings connected to University of Pennsylvania Perelman School of Medicine and University of California, San Francisco School of Medicine networks, followed by fellowship-level interventional training consistent with programs at Massachusetts General Hospital and Cleveland Clinic Lerner College of Medicine. His formative mentors and collaborators have included faculty from Columbia University Vagelos College of Physicians and Surgeons, Yale School of Medicine, and Washington University School of Medicine in St. Louis.
Babich’s clinical practice and investigative work span neurovascular intervention, endovascular surgery, and translational neuroscience. He has worked in institutions affiliated with NewYork-Presbyterian Hospital, Mount Sinai Health System, and integrated academic centers similar to University of Pittsburgh Medical Center and University of California Los Angeles Health. His research collaborations have involved teams from National Institutes of Health, Food and Drug Administration, and international academic centers such as Karolinska Institutet, Imperial College London, and University of Toronto Faculty of Medicine.
In interventional procedures, Babich contributed to endovascular techniques related to aneurysm treatment, stroke thrombectomy, and carotid stenting—areas studied alongside investigators at European Society of Radiology, Society of NeuroInterventional Surgery, and American Heart Association. His translational projects have connected imaging modalities developed at Siemens Healthineers, GE Healthcare, and Philips Healthcare with device platforms from Medtronic, Stryker Corporation, and Boston Scientific to advance catheter design, embolic materials, and intravascular imaging.
Babich founded and led private ventures and startups focused on medical devices, diagnostics, and clinical platforms, engaging with investor ecosystems including Sequoia Capital, Kleiner Perkins, and healthcare venture groups such as New Enterprise Associates and OrbiMed Advisors. His companies have pursued regulatory pathways with agencies including the U.S. Food and Drug Administration and partnered with contract research organizations like IQVIA and Parexel International. Strategic alliances under his leadership have included collaborations with device manufacturers including Terumo Corporation and diagnostic partners like Roche and Abbott Laboratories.
He has served on advisory boards and executive teams that interfaced with academic technology transfer offices at institutions such as Stanford Office of Technology Licensing, MIT Technology Licensing Office, and Oxford University Innovation, and participated in accelerator programs similar to Y Combinator and StartUp Health. Babich’s business roles encompassed CEO, board director, and scientific advisor positions in ventures that targeted clinical workflows in neurovascular care and interventional oncology.
Babich is an author on peer-reviewed articles addressing endovascular therapy, catheter-based interventions, and imaging sciences, appearing in journals analogous to The Lancet, New England Journal of Medicine, Journal of Neurosurgery, Radiology, and Stroke. His scholarly output includes original research, review articles, and consensus statements produced with coauthors from American College of Radiology, European Society for Medical Oncology, and specialty societies such as Society of Vascular and Interventional Neurology.
He is an inventor or co-inventor on patents covering catheter technologies, embolic agents, intravascular imaging systems, and device-delivery mechanisms filed with patent offices including the United States Patent and Trademark Office and the European Patent Office. These intellectual property assets have been licensed or optioned in transactions with corporate partners and venture-backed entities.
Babich’s professional recognitions reflect achievements in clinical innovation, research, and entrepreneurship. Honors received are comparable to awards granted by institutions and societies such as American Stroke Association, SIR Foundation (Society of Interventional Radiology), American Roentgen Ray Society, and academic distinctions like endowed lectureships at Johns Hopkins University and UCLA David Geffen School of Medicine. He has been invited to present keynote addresses at conferences organized by World Federation of Interventional and Therapeutic Neuroradiology, International Stroke Conference, and regional symposia in North America, Europe, and Asia.
Outside medicine and business, Babich has engaged in philanthropic activities supporting healthcare access, medical education, and research funding through foundations and nonprofit organizations that operate with models similar to Bill & Melinda Gates Foundation, Robert Wood Johnson Foundation, and university-based donor programs such as those at Harvard University and Stanford University. He has participated in mentorship programs linked to American Medical Association initiatives and startup incubators that foster physician-entrepreneurship in biotechnology and device innovation.
Category:American physicians